Affymetrix Cuts Q2 Revenue Outlook by $6M To $14M as Demand for Chips, Spotters Falls | GenomeWeb

Affymetrix reduced its revenue expectations sharply for the second quarter, saying that both sales of GeneChip products and do-it-yourself arraying equipment have slowed significantly in recent months.

The company said its revenues for the quarter would total between $44 and $50 million, or between $6 and $12 million less than previously predicted second-quarter revenues of between $56 million and $58 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.